Just listened to the Goldman Sachs presentation and one of Harvey's first statements left me wondering. At the beginning of his prentation, and in response to what his legacy will be, Harvey said that he is proud of the two drugs that Ariad producd (obviously referring to Icluisig and Brigatinib) and mentioned that they will be followed by three (3) others, and of the five, three are in the oncology field (I am sure that was Iclusig, Brigatinib and 788) and the other two (2) will be for other indications.
Does anyone here have any information on the other two that Harvey was referring to? Perhaps someone has heard some reference to these other two candidates, at one of the Medical Conferences, other presentations, facebook or annual meetings?
Barry
